Medical Oncologist
CION Cancer Clinics
BARD1 mutation: which cancers, and how much risk | CION Cancer Clinics
An inherited BARD1 fault mainly raises the risk of breast cancer, especially the triple-negative type. The rise is moderate, clearly above other women but below a BRCA1 fault. No clear link to ovarian or other cancers has been shown so far. This page explains what is known, what is still uncertain, and how your family history changes the picture. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Which cancers does a BARD1 fault raise the risk of?
- What does the evidence say for each cancer?
- How does a BARD1 carrier's risk change with age?
- The words you will hear about risk, in plain language
- What is known about BARD1, and what is still uncertain?
- What this page cannot tell you
- Four things families tell us, and what is actually true
- Common questions about BARD1 and cancer risk
The short answer
Which cancers does a BARD1 fault raise the risk of?
An inherited BARD1 fault mainly raises the risk of breast cancer, especially the triple-negative type. The rise is moderate, clearly above other women but well below a BRCA1 fault. A clear link to ovarian cancer or other cancers has not been shown so far.
Why the risk is called moderate
Genes linked to breast cancer fall into rough groups. BRCA1 and BRCA2 sit at the top. BARD1 sits in a middle group with genes such as CHEK2. A moderate risk usually means closer breast screening rather than preventive surgery, though the plan depends on your family history too.
Why the numbers are still uncertain
BARD1 was added to routine panel tests only in recent years. Faults in it are rare, so studies so far are small. Estimates of the breast cancer risk differ between studies, and very few include Indian women. What is settled is that the risk is raised. What is not settled is exactly by how much for any one woman.
Where your family history comes in
Two women with the same BARD1 fault can have different risks. A woman whose mother and sister had breast cancer young is at higher risk than a carrier with no affected relatives. Your counsellor weighs both.
A BARD1 fault is a statement about risk. It is not a cancer diagnosis.Cancer by cancer
What does the evidence say for each cancer?
One risk is clear. The rest are either not raised, as far as anyone can tell, or not yet studied well enough to say.
Breast cancer
The one risk that is clearly raised. It is the reason BARD1 is on breast cancer panels and the reason carriers are offered closer breast screening.
Usually managed by
- Breast screening starting earlier than usual
- MRI added in some women
- Knowing your own breasts and reporting changes
Triple-negative breast cancer
BARD1 faults are found more often in women with this type, which lacks three common receptors. Indian women are diagnosed with it more often than women in the West, which is one reason panel testing is now widely offered here.
Ovarian cancer
No clear raised risk has been shown so far. This is a key difference from BRCA1. Preventive removal of the ovaries is not usually advised for a BARD1 fault alone.
Other cancers
Links to pancreatic, prostate and other cancers have been looked for but not established. Men who carry the fault are not known to face a clearly raised risk themselves, but they can pass it to daughters.
Not sure whether this applies to you?
Ask an oncologistAcross a lifetime
How does a BARD1 carrier's risk change with age?
-
Childhood and the teenage years
No known risk and no checks needed. This is why testing children for BARD1 is not usually advised. They can decide for themselves as adults.
-
Early adulthood
Breast cancer is still uncommon. This is a good time to learn what your breasts normally feel like, and to think about family plans with the result in mind.
-
Middle adult life
Closer breast screening usually begins, earlier than for women at ordinary risk. The exact starting point is set by your specialist from your family history.
-
After a breast cancer
A woman who has already had breast cancer may face a raised risk in the other breast. How much is not yet clear for BARD1, and your team will plan follow-up with that in mind.
-
Later life
Breast screening carries on. The plan is reviewed as new studies report, because advice for BARD1 is still developing.
On your report
The words you will hear about risk, in plain language
- Moderate-penetrance gene
- A gene whose faults raise risk clearly, but less than the highest-risk genes such as BRCA1.
- Lifetime risk
- The chance of developing a cancer at any point in life, not in the next year or the next decade.
- Relative risk
- How many times higher your risk is than other people's. It sounds large but says little on its own.
- Absolute risk
- Your actual chance, out of every hundred women like you. This is the figure that helps decisions.
- Risk model
- A calculation that combines the gene result with your family history and other factors to give a personal estimate.
- Triple-negative
- A breast cancer lacking three receptors that many treatments target. It is the type most linked with BARD1.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What is known about BARD1, and what is still uncertain?
What the evidence shows
What is still uncertain
Breast cancer risk is raised
Exactly how much, for any one woman
Triple-negative cancer is linked most strongly
How much other breast cancer types are raised
No clear ovarian risk has been shown
Whether a small ovarian risk exists
Closer breast screening is reasonable
Whether preventive surgery adds benefit
Relatives can be tested for the same fault
The risk in families with no breast cancer
Being straight with you
What this page cannot tell you
It cannot give you a personal risk figure. That needs your family history, your age and the exact fault, run through a risk model by someone trained to do it. What your specific variant means is a question for the counsellor who ordered the test.
It cannot tell you about treatment
Whether a BARD1 fault changes the treatment of a breast cancer you already have is a separate question. Evidence is limited, and it is one for your oncologist. Faults found only inside a tumour are handled by our targeted therapy team and are not inherited.
Who this does not apply to
Most women with breast cancer do not carry a BARD1 fault, and most women without a strong family history do not need a BARD1 test. If your report shows a variant of uncertain significance, meaning the laboratory does not yet know whether it matters, this page does not describe you. It should not change your screening or lead to surgery.
Commonly believed
Four things families tell us, and what is actually true
"BARD1 is just like BRCA1, so I need the same surgery."
The two genes work together, but the risks are not the same. BARD1 raises breast cancer risk less steeply and has no clear ovarian link. Closer screening is the usual plan, and surgery is discussed only in some families.
"Only the women in the family need to know."
Men can carry and pass on a BARD1 fault exactly as women can. A father's daughters each have a one in two chance of inheriting it. Brothers should be told too.
"A moderate risk means I can ignore it."
Moderate still means raised. Closer breast screening finds cancers earlier, when treatment is simpler. Skipping it wastes the one real advantage the result gives you.
"The numbers online tell me my exact risk."
Published figures come from small studies, mostly outside India, and they vary. Your own estimate depends on your family history, which no website knows.
Questions we are asked
Common questions about BARD1 and cancer risk
How high is the breast cancer risk with BARD1?
It is moderately raised, clearly above other women but well below BRCA1 or BRCA2. Studies give different estimates because they are small. Your personal figure depends on your family history and should be worked out with a counsellor using a risk model.
Do I need my ovaries removed?
Not usually for a BARD1 fault alone, because no clear ovarian cancer risk has been shown. If ovarian cancer runs in your family, your counsellor may look for another cause. Any decision about surgery should follow a proper discussion, never a report alone.
Should I think about preventive mastectomy?
For most BARD1 carriers, closer screening is the usual plan instead. Preventive surgery may be discussed when the family history is strong. It is one option among several, and there is a separate page on risk-reducing surgery if you want to read more.
Does a BARD1 fault affect men?
A clearly raised risk in men has not been shown. But a man can carry the fault and pass it to his children, each of whom has a one in two chance of inheriting it. That matters most for his daughters.
Is BARD1 linked to triple-negative breast cancer?
Yes. BARD1 faults are found more often in women with triple-negative breast cancer than in women with other types. This is one reason panel testing is offered to many women diagnosed with this type, especially at a younger age.
Will the risk estimate change in future?
Probably. Studies of BARD1 are growing, and the estimate may be refined up or down. Ask your counsellor how you will be told about new advice, and keep your report somewhere safe so you can bring it to later appointments.
Should my children be tested for BARD1?
Not in childhood, because there is no known risk and nothing to check at that age. Adult children, especially daughters, can be offered a test for the family fault. Each decides for themselves after counselling.
Who should I talk to about my own risk?
A genetic counsellor or clinical geneticist, working with a breast specialist. Bring your report and the family history on both sides. Call the CION helpline to arrange an appointment, with counselling in Telugu if you prefer.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NCCN — Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ) - Health Professional Version
- National Cancer Institute — Genetic Testing for Inherited Cancer Susceptibility Syndromes
- Cancer Research UK — Inherited cancer genes and increased cancer risk
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Want to know what a BARD1 result means for you?
Bring your report and your family history, and we will help arrange counselling and a breast screening plan. One helpline serves every CION centre.